Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GeneDx Holdings Corp.CL A(WGS) | 3,507,164 | 3,007,164 | -500,000 | $323.75M | $323.99M | 27.01% | +$245.5K |
| Biolife Solutions Inc | 7,707,165 | 6,707,165 | -1,000,000 | $166.01M | $171.10M | 14.27% | +$5.09M |
| Revolution Medicines, Inc.(RVMD) | 2,887,933 | 2,647,333 | -240,600 | $106.25M | $123.63M | 10.31% | +$17.38M |
| Standard BioTools Inc.(LAB) | 76,075,636 | 77,558,856 | +1,483,220 | $91.29M | $100.83M | 8.41% | +$9.54M |
| Avidity Biosciences Inc | 1,775,000 | 1,780,000 | +5,000 | $50.41M | $77.55M | 6.47% | +$27.14M |
| Relay Therapeutics, Inc.(RLAY) | 11,398,574 | 11,341,381 | -57,193 | $39.44M | $59.20M | 4.94% | +$19.76M |
| Illumina, Inc.(ILMN) | 645,000 | 525,000 | -120,000 | $61.54M | $49.86M | 4.16% | -$11.68M |
| Structure Therapeutics IncADS | 1,225,000 | 1,555,000 | +330,000 | $25.41M | $43.54M | 3.63% | +$18.13M |
| Beam Therapeutics Inc.(BEAM) | 1,450,000 | 1,600,000 | +150,000 | $24.66M | $38.83M | 3.24% | +$14.17M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 81,500 | 55,000 | -26,500 | $26.58M | $25.08M | 2.09% | -$1.50M |
| Tempus AI, Inc.CL A(TEM) | 0 | 294,127 | +294,127 | $0 | $23.74M | 1.98% | +$23.74M |
| Neurogene Inc.(NGNE) | 1,295,361 | 1,295,361 | 0 | $19.37M | $22.45M | 1.87% | +$3.08M |
| Maze Therapeutics, Inc.(MAZE) | 758,857 | 758,857 | 0 | $9.31M | $19.68M | 1.64% | +$10.37M |
| Prime Medicine, Inc.(PRME) | 1,567,175 | 3,167,175 | +1,600,000 | $3.87M | $17.55M | 1.46% | +$13.68M |
| ARS Pharmaceuticals, Inc.(SPRY) | 0 | 1,600,000 | +1,600,000 | $0 | $16.08M | 1.34% | +$16.08M |
| Hims & Hers Health, Inc.CL A(HIMS) | 230,000 | 230,000 | 0 | $11.47M | $13.05M | 1.09% | +$1.58M |
| Denali Therapeutics Inc.(DNLI) | 890,000 | 890,000 | 0 | $12.45M | $12.92M | 1.08% | +$471.7K |
| Septerna, Inc.(SEPN) | 553,268 | 553,268 | 0 | $5.85M | $10.41M | 0.87% | +$4.56M |
| Veracyte, Inc.(VCYT) | 276,308 | 276,308 | 0 | $7.47M | $9.49M | 0.79% | +$2.02M |
| UnitedHealth Group Incorporated(UNH) | 0 | 25,000 | +25,000 | $0 | $8.63M | 0.72% | +$8.63M |
| Incyte Corporation(INCY) | 0 | 100,000 | +100,000 | $0 | $8.48M | 0.71% | +$8.48M |
| Guardant Health, Inc.(GH) | 100,000 | 100,000 | 0 | $5.20M | $6.25M | 0.52% | +$1.04M |
| Endeavour Silver Corp.(EXK) | 90,000 | 90,000 | 0 | $4.78M | $4.92M | 0.41% | +$141.3K |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 282,312 | +282,312 | $0 | $3.27M | 0.27% | +$3.27M |
| Absci Corporation | 973,260 | 973,260 | 0 | $2.50M | $2.96M | 0.25% | +$457.4K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 148,333 | 148,333 | 0 | $588.9K | $1.74M | 0.15% | +$1.15M |
| Pacific Biosciences of California, Inc.(PACB) | 723,767 | 723,767 | 0 | $897.5K | $926.4K | 0.08% | +$29.0K |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 165,323 | 165,323 | 0 | $836.5K | $806.8K | 0.07% | -$29.8K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 86,014 | 86,014 | 0 | $387.9K | $637.4K | 0.05% | +$249.4K |
| Century Therapeutics, Inc.(IPSC) | 1,228,190 | 1,228,190 | 0 | $686.2K | $611.6K | 0.05% | -$74.6K |
| Tenaya Therapeutics, Inc.(TNYA) | 361,969 | 361,969 | 0 | $221.2K | $586.4K | 0.05% | +$365.2K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 36,493 | 36,493 | 0 | $410.5K | $532.1K | 0.04% | +$121.5K |
| Agios Pharmaceuticals, Inc.(AGIO) | 100,000 | 0 | -100,000 | $3.33M | $0 | — | -$3.33M |
| Codexis, Inc.(CDXS) | 7,200,000 | 0 | -7,200,000 | $17.57M | $0 | — | -$17.57M |
| Eli Lilly and Company(LLY) | 8,500 | 0 | -8,500 | $6.63M | $0 | — | -$6.63M |
| Sarepta Therapeutics, Inc.(SRPT) | 990,097 | 0 | -990,097 | $16.93M | $0 | — | -$16.93M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 650,000 | 0 | -650,000 | $6.08M | $0 | — | -$6.08M |
| Verve Therapeutics Inc | 4,095,571 | 0 | -4,095,571 | $45.99M | $0 | — | -$45.99M |